EraGen Gets Nod to Market Five RT-PCR Tests in Canada | GenomeWeb
NEW YORK (GenomeWeb News) - EraGen Biosciences said today that it has received Health Canada approval to market five quantitative PCR-based in vitro diagnostics in the Canadian market.
Health Canada approved the company’s tests for Bordetella pertussis and B. parapertussis; Enterovirus; influenza types A and B; herpes simplex virus 1 and 2; and cytomegalovirus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.